HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells

Journal of Clinical Investigation

Volumn 108, Issue 3, 2001, Pages 399-405

  Llevadot, Joan ^a   Murasawa, Satoshi ^a   Kureishi, Yasuko ^a   Uchida, Shigeki ^a   Masuda, Haruchika ^a   Kawamoto, Atsuhiko ^a   Walsh, Kenneth ^a   Isner, Jeffrey M ^a,c   Asahara, Takayuki ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOKAI UNIVERSITY   (Japan)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; RECOMBINANT VASCULOTROPIN; SIMVASTATIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORNEA; ENDOTHELIUM CELL; ENZYME INHIBITION; GROWTH STIMULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CHEMOTAXIS; CORNEA; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELLS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LYMPHOKINES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SIMVASTATIN; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034898468     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200113131     Document Type: Article

References (40)

1. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies
2. Isolation of putarive progenitor endothelial cells for angiogenesis
3. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
4. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
5. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
6. Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects
7. 165 in patients with inoperable coronary disease
8. Evidence for circulating bone marrow-derived endothelial cells
9. Isolation and characterization of endochelial progenitor cells from mouse embryos
10. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells
11. In vivo differentiation of endothelial cells from AC133-positive progenitor cells
12. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation
13. Contribution of monocytes/macrophages to compensatory neovascularization. The drilling of metalloelastase-positive tunnels in ischemic myocardium
14. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization
15. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit
16. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/akt signal transduction pathway
17. Angiopoietin-1 inhibits endothelial cell apoptosis via the akt/survivin pathway
18. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
19. Vascular endothelial growth factor-stimulated actin reorganization and migration of encdothelial cells is regulated via the serine/threonine kinase akt
20. Regulation of endothelium-derived nitric oxide production by the protein kinase akt
21. Activation of nitric oxide synthase in endothelial cells by akt-dependent phosphorylation
22. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase akt and promotes angiogenesis in normocholesrerolemic animals
23. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts
24. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization
25. Vascular endothelial lineage-specific promoter in transgenic mice
26. Angiogenesis in the mouse cornea
27. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovasculatization
28. Angiogenesis
29. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase
30. Matrix adhesion and ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase b/akt cellular survival pathway
31. Direct regulation of the akt proto-oncogene product by phosphatidylinositol-3,4-bishosphate
32. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line
33. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons
34. Specific TrkA survival signals interfere with different apoptotic pathways
35. Akt takes center stage in angiogenesis signaling
36. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
37. Tyrosine 1101 of tie2 is the major site of association of p85 and is required for activation ofphosphatidylinositol 3-kinase and akt
38. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-tepetfusion injury in mouse heart
39. Acute modulation of endothelial akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo
40. Stimulation of bone formation in vitro and in rodents by statins